Bioveta
Bioveta a.s. is a Czech veterinary pharmaceutical company, founded in 1918, that develops, manufactures, and distributes vaccines, pharmaceuticals, antiparasitics, and nutraceuticals for livestock and companion animals, exporting to more than 90 countries through international distribution partners, a Russian subsidiary, and a Czech e-commerce storefront.
- Company typePrivate
- Founded1918
- HeadquartersIvanovice Na Hané, Czechia
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Bioveta does
Bioveta a.s. is a privately held Czech veterinary pharmaceutical company headquartered in Ivanovice na Hané. Founded in 1918, it develops, manufactures, and distributes a broad portfolio of veterinary medicinal products for both production animals (cattle, pigs, poultry, sheep, goats) and companion animals (dogs, cats, horses, rabbits). The integrated manufacturing footprint is anchored at a single site in the Czech Republic, and products are exported to more than 90 countries through localized websites in eight languages (Czech, English, Slovak, Polish, Romanian, Russian, Turkish, Ukrainian), a wholly-owned Russian subsidiary (Bioveta Rusko), and channel partners including Lekoom AD in Bulgaria and Salfarm in Denmark.
The product portfolio spans vaccines (BioBos BTV multi-serotype line for bluetongue, BioBos IBR Marker, Trichoben for cattle ringworm with at least five-year immunity, Kolibin RC Neo for neonatal calf enteric infections, Biocan Novel for companion animals), pharmaceutical preparations (Jodouter intrauterine povidone-iodine solution, Amoxicillin Bioveta LA), antiparasitics (Fipron spot-on, Top Spot On, Bio Kill, MIZIVERM), dermatologicals (BioDexin, Otipur, Alaptid ointment), nutraceuticals (ATLET BS, ATLET MSM, ATLET Syrup, ATLET ProDrink), and diagnostics. Differentiation rests on cattle-vaccine R&D (e.g., 5-year Trichoben immunity, colostral passive protection via Kolibin RC Neo) and a diversified multi-species offering rather than on any platform technology.
Bioveta generates revenue primarily through one-time sales of its veterinary medicines to distributors, veterinary clinics, and animal-shelter/CSR channels internationally, with a direct-to-consumer e-commerce storefront (biovetapets.cz) for pet products in the Czech Republic. Go-to-market is channel-partner and event-driven: heavy participation in veterinary trade shows (EuroTier, IPPE, VIV Asia, ESPHM, VIV MEA, VetME Dubai), co-hosted workshops and seminars with regional distributors, a quarterly corporate publication (Bioveta News since 2008), and social channels (Facebook, Instagram). Pricing is not publicly disclosed; the company is described as a private joint-stock company with no identified external shareholders or funding rounds.
Bioveta firmographics
Firmographics- Name
- Bioveta
- Legal name
- Bioveta a.s.
- Website
- https://bioveta.cz
- Company type
- Private
- Founded year
- 1918
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Bioveta a.s. is a Czech veterinary pharmaceutical company, founded in 1918, that develops, manufactures, and distributes vaccines, pharmaceuticals, antiparasitics, and nutraceuticals for livestock and companion animals, exporting to more than 90 countries through international distribution partners, a Russian subsidiary, and a Czech e-commerce storefront.
- Ownership category
- akta.pro rank
Bioveta industry classification
Industry- Product category
- Veterinary Pharmaceuticals
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Veterinary Vaccines (Biologics) (HLAMAEAL)
- akta.pro secondary industries
- Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB), Antimicrobials & Anti-infectives (HLAMAEAE), Veterinary Vaccines (HLAIAEAH)
Keywords
Where Bioveta is headquartered
LocationHeadquarters
- HQ city
- Ivanovice Na Hané
- HQ country
- Czechia
- HQ region
- Europe
Offices1 record
Markets served
Bioveta business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Veterinary Pharmaceuticals: Sale of veterinary medicinal products including vaccines, antibiotics, antiparasitics, dermatological products, hormones, and diagnostic products for livestock and companion animals.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Bioveta product offering
Product offeringCore offering
Bioveta is a Czech veterinary pharmaceutical company that manufactures veterinary medicinal products using modern technologies. Its portfolio covers vaccines (inactivated and live attenuated), injectable solutions, intrauterine preparations, topical products, antiparasitics, dermatological products, hormonal treatments, nutraceuticals, and diagnostic products for livestock (cattle, pigs, poultry, sheep, goats) and companion animals (dogs, cats, horses, rabbits). The company exports to more than 90 countries worldwide and has been in continuous operation since 1918.
Product overview
Bioveta a.s. is a Czech veterinary pharmaceutical company manufacturing veterinary medicinal products using modern technologies. The product portfolio includes vaccines (KOLIBIN RC NEO, TRICHOBEN, BioBos BTV line for bluetongue, BioBos IBR Marker, Biocan Novel), pharmaceutical preparations (JODOUTER intrauterine solution, AMOXICILLIN BIOVETA LA), dermatological products (ALAPTID ointment, BIODEXIN, OTIPUR), antiparasitics (FIPRON, TOP SPOT ON, BIO KILL), joint nutrition supplements (ATLET BS, ATLET MSM, ATLET Syrup), vitamins (ADE-VIT), and diagnostic products (AVITUBAL). The company exports to more than 90 countries worldwide and publishes the Bioveta News magazine for veterinary professionals.
Differentiator
Problem solved
Functional benefit
Brands
- Biocan Novel: A new line of vaccines presented at VRVC Thailand 2017 for registration in Thailand and Philippines
- BioBos
- ATLET
- Bioveta News
Products and services
- KOLIBIN RC NEO
Companies that use Bioveta
Customer profileSegments3 records
Ideal customer profiles3 records
Bioveta technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Bioveta partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered minor, core and major.
- Ukrainian Association of Small Animal Veterinary Medicine (USAVA-VNAU)minorBioveta was a partner of the Ukrainian online veterinary congress USAVA-VNAU 2020, featuring international speakers including Dr. Jiří Neužil (Regional Director for Ukraine) presenting on immunology and vaccination trends, and Professor Miroslav Svoboda presenting on dermatology.
- Bioveta Rusko (Bioveta Russia)coreRussian subsidiary that represents Bioveta at international exhibitions in Russia including MVC: Cereals - Mixed Feed - Veterinary trade show in Moscow. The subsidiary handles distribution and representation in the Russian market.
- Lekoom ADmajorBulgarian company Lekoom AD is the largest distributor of Bioveta products in Bulgaria. The companies co-organize educational seminars for Bulgarian veterinarians on topics including dermatology and immunology of dogs and cats. Lekoom distributes the full range of Bioveta products including vaccines, antiparasitics, and other veterinary preparations.
- SalfarmminorDanish partner company with whom Bioveta co-exhibited at the 9th European Symposium of Porcine Health Management (ESPHM) in Prague in May 2017. Salfarm serves as Bioveta's distribution partner in Denmark.
- Psí hvězda FoundationminorBioveta, together with the Psí hvězda Foundation, provided combined vaccines to protect dogs from the Kamenice puppy mill case. Vaccines were delivered to veterinarians providing care at animal shelters including Dejte nám šanci, Russell Rescue, Dočasky.cz, Záchranné depozitum pro psy Beruška, and Azyl Dej Pac.
Scale indicators1 record
Recent moves6 records
Expansion highlights5 records
Bioveta competitors and assessment
Company assessmentBroad incumbents
- Elanco Animal Health: Large global animal health company with a broad portfolio across livestock and companion animals; competes with Bioveta across multiple therapeutic categories but at much greater scale.
- MSD Animal Health: Division of Merck offering veterinary vaccines, antiparasitics, and pharmaceuticals across species — overlapping product categories (BTV, IBR, companion animal vaccines) with Bioveta and a much larger global footprint.
- Zoetis: Global leader in animal health and veterinary pharmaceuticals with a comprehensive vaccine and therapeutics portfolio across livestock and companion animals — directly comparable value chain but significantly larger scale and R&D budget than Bioveta.
- Boehringer Ingelheim Animal Health: Major veterinary vaccines and pharmaceuticals player with strengths in livestock and companion animal biologics; competes with Bioveta in the same veterinary biologics and pharmaceutical preparation categories globally.
Direct peers
- Phibro Animal Health: Mid-size animal health company focused on livestock pharmaceuticals, vaccines, and nutrition specialties — directly comparable mid-cap veterinary pharma business with similar species emphasis and product breadth.
- IDT Biologika: German veterinary biologics manufacturer with deep expertise in livestock vaccines (BTV, IBR) and contract manufacturing; competes most directly with Bioveta's inactivated-vaccine portfolio in the European bluetongue market.
- Virbac: Mid-size French veterinary pharmaceutical group focused exclusively on animal health with a comparable product mix (vaccines, antiparasitics, dermatology, supplements) and a similar private/independent ownership profile; closest analog to Bioveta in size and strategy.
- Vetoquinol: Independent French veterinary pharmaceutical company of similar mid-cap scale, manufacturing vaccines and therapeutics for livestock and companion animals; directly comparable specialty animal-health peer.
- Huvepharma: Bulgarian-headquartered animal health and nutrition company producing veterinary pharmaceuticals, vaccines, and feed additives; a regional peer with a similar Eastern European manufacturing base and CEE market presence.
- Ceva Santé Animale: Privately held French veterinary pharmaceutical company specializing in vaccines, reproduction, and livestock pharmaceuticals — directly comparable portfolio emphasis and ownership structure to Bioveta.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Bioveta social profiles
Digital presenceBioveta financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bioveta leadership team
Management profileNumber of profiles
Profiles3 records
Bioveta subsidiaries and ownership
Company hierarchySubsidiaries1 record
Bioveta funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bioveta M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bioveta
What does Bioveta do?
Bioveta is a Czech veterinary pharmaceutical company that manufactures veterinary medicinal products using modern technologies. Its portfolio covers vaccines (inactivated and live attenuated), injectable solutions, intrauterine preparations, topical products, antiparasitics, dermatological products, hormonal treatments, nutraceuticals, and diagnostic products for livestock (cattle, pigs, poultry, sheep, goats) and companion animals (dogs, cats, horses, rabbits). The company exports to more than 90 countries worldwide and has been in continuous operation since 1918.
Is Bioveta a public or private company?
Bioveta is a private company. It is classified as unknown and is currently operating.
When was Bioveta founded?
Bioveta was founded in 1918. It employs 101 to 250 people.
Where is Bioveta based?
Bioveta is headquartered in Ivanovice Na Hané, Czechia, in the Europe region.
How does Bioveta make money?
One revenue line is on record: veterinary Pharmaceuticals.
Who are Bioveta's main competitors?
Broad incumbents on record are Elanco Animal Health, MSD Animal Health, Zoetis and Boehringer Ingelheim Animal Health. Direct peers are Phibro Animal Health, IDT Biologika, Virbac, Vetoquinol, Huvepharma and Ceva Santé Animale.
Does Bioveta have an API?
No public API is recorded for Bioveta.
What industry is Bioveta in?
Bioveta's product category is Veterinary Pharmaceuticals. Its primary akta.pro industry code is HLAMAEAL, Veterinary Vaccines (Biologics), with a secondary code of HLAMAEAB, Livestock & Production Animal Therapeutics (Rx). Its NAICS code is 325414 and its SIC code is 2836.